Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Diagnostic value of highly-sensitive chimerism analysis after allogeneic stem cell transplantation.

Sellmann L, Rabe K, Bünting I, Dammann E, Göhring G, Ganser A, Stadler M, Weissinger EM, Hambach L.

Bone Marrow Transplant. 2018 Nov;53(11):1457-1465. doi: 10.1038/s41409-018-0176-7. Epub 2018 May 2.

PMID:
29720704
2.

Overall survival in non-small cell lung cancer-what is clinically meaningful?

Fenchel K, Sellmann L, Dempke WC.

Transl Lung Cancer Res. 2016 Feb;5(1):115-9. doi: 10.3978/j.issn.2218-6751.2016.01.06.

3.

Immunotherapies for NSCLC: Are We Cutting the Gordian Helix?

Dempke WC, Sellmann L, Fenchel K, Edvardsen K.

Anticancer Res. 2015 Nov;35(11):5745-57. Review.

PMID:
26503995
4.

Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.

Peveling-Oberhag J, Wolters F, Döring C, Walter D, Sellmann L, Scholtysik R, Lucioni M, Schubach M, Paulli M, Biskup S, Zeuzem S, Küppers R, Hansmann ML.

BMC Cancer. 2015 Oct 24;15:773. doi: 10.1186/s12885-015-1766-z.

5.

Shorter telomeres correlate with an increase in the number of uniparental disomies in patients with chronic lymphocytic leukemia.

Sellmann L, Scholtysik R, de Beer D, Eisele L, Klein-Hitpass L, Nückel H, Dührsen U, Dürig J, Röth A, Baerlocher GM.

Leuk Lymphoma. 2016;57(3):590-5. doi: 10.3109/10428194.2015.1076929. Epub 2015 Oct 12.

PMID:
26457386
6.

Improved overall survival following tyrosine kinase inhibitor treatment in advanced or metastatic non-small-cell lung cancer-the Holy Grail in cancer treatment?

Sellmann L, Fenchel K, Dempke WC.

Transl Lung Cancer Res. 2015 Jun;4(3):223-7. doi: 10.3978/j.issn.2218-6751.2015.03.01.

7.

Expanded CD8+ T cells of murine and human CLL are driven into a senescent KLRG1+ effector memory phenotype.

Göthert JR, Eisele L, Klein-Hitpass L, Weber S, Zesewitz ML, Sellmann L, Röth A, Pircher H, Dührsen U, Dürig J.

Cancer Immunol Immunother. 2013 Nov;62(11):1697-1709.

PMID:
24022692
8.

Cellular origin and pathophysiology of chronic lymphocytic leukemia.

Seifert M, Sellmann L, Bloehdorn J, Wein F, Stilgenbauer S, Dürig J, Küppers R.

J Exp Med. 2012 Nov 19;209(12):2183-98. doi: 10.1084/jem.20120833. Epub 2012 Oct 22.

9.

p53 protein expression in chronic lymphocytic leukemia.

Sellmann L, Carpinteiro A, Nückel H, Scholtysik R, Siemer D, Klein-Hipass L, Kube D, Dürig J, Dührsen U, Stanelle J, Küppers R.

Leuk Lymphoma. 2012 Jul;53(7):1282-8. doi: 10.3109/10428194.2011.654115. Epub 2012 Feb 13.

PMID:
22220854
10.

Telomeres and prognosis in patients with chronic lymphocytic leukaemia.

Sellmann L, de Beer D, Bartels M, Opalka B, Nückel H, Dührsen U, Dürig J, Seifert M, Siemer D, Küppers R, Baerlocher GM, Röth A.

Int J Hematol. 2011 Jan;93(1):74-82. doi: 10.1007/s12185-010-0750-2. Epub 2011 Jan 5.

PMID:
21203871
11.

Gene dosage effects in chronic lymphocytic leukemia.

Sellmann L, Scholtysik R, Kreuz M, Cyrull S, Tiacci E, Stanelle J, Carpinteiro A, Nückel H, Boes T, Gesk S, Siebert R, Klein-Hitpass L, Dührsen U, Dürig J, Küppers R.

Cancer Genet Cytogenet. 2010 Dec;203(2):149-60. doi: 10.1016/j.cancergencyto.2010.09.002.

PMID:
21156227
12.

Intravascular large B-cell lymphoma within a subcutaneous cavernous haemangioma.

Krokowski M, Sellmann L, Feller AC.

Br J Haematol. 2010 Oct;151(1):2. doi: 10.1111/j.1365-2141.2010.08324.x. Epub 2010 Aug 5. No abstract available.

PMID:
20735401
13.

The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia.

Nückel H, Switala M, Sellmann L, Horn PA, Dürig J, Dührsen U, Küppers R, Grosse-Wilde H, Rebmann V.

Leukemia. 2010 Jun;24(6):1152-9. doi: 10.1038/leu.2010.74. Epub 2010 Apr 29.

PMID:
20428196
14.

Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia.

Johansson P, Eisele L, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J, Nückel H.

Leuk Res. 2010 Jul;34(7):892-8. doi: 10.1016/j.leukres.2010.02.038. Epub 2010 Mar 29.

PMID:
20353875
15.

FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia.

Nückel H, Collins CH, Frey UH, Sellmann L, Dürig J, Siffert W, Dührsen U.

Eur J Haematol. 2009 Dec 1;83(6):541-9. doi: 10.1111/j.1600-0609.2009.01328.x. Epub 2009 Aug 4.

PMID:
19682311
16.

High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia.

Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V.

Clin Immunol. 2009 Jun;131(3):472-80. doi: 10.1016/j.clim.2009.02.004. Epub 2009 Mar 24.

PMID:
19318232
17.

The IKZF3 (Aiolos) transcription factor is highly upregulated and inversely correlated with clinical progression in chronic lymphocytic leukaemia.

Nückel H, Frey UH, Sellmann L, Collins CH, Dührsen U, Siffert W.

Br J Haematol. 2009 Jan;144(2):268-70. doi: 10.1111/j.1365-2141.2008.07442.x. Epub 2008 Nov 11. No abstract available.

PMID:
19016725
18.

Expression levels of CD38 on leukemic B cells but not on non-leukemic T cells are comparably stable over time and predict the course of disease in patients with chronic lymphocytic leukemia.

Eisele L, Haddad T, Sellmann L, Dührsen U, Dürig J.

Leuk Res. 2009 Jun;33(6):775-8. doi: 10.1016/j.leukres.2008.09.001. Epub 2008 Oct 14.

PMID:
18922578
19.

Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukaemia.

Röth A, de Beer D, Nückel H, Sellmann L, Dührsen U, Dürig J, Baerlocher GM.

Br J Haematol. 2008 Nov;143(3):383-6. doi: 10.1111/j.1365-2141.2008.07363.x. Epub 2008 Aug 28.

PMID:
18759763
20.

Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells.

Edelmann J, Klein-Hitpass L, Carpinteiro A, Führer A, Sellmann L, Stilgenbauer S, Dührsen U, Dürig J.

Leuk Res. 2008 Oct;32(10):1565-72. doi: 10.1016/j.leukres.2008.03.003. Epub 2008 Apr 14.

PMID:
18407351
21.

A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.

Dürig J, Ebeling P, Grabellus F, Sorg UR, Möllmann M, Schütt P, Göthert J, Sellmann L, Seeber S, Flasshove M, Dührsen U, Moritz T.

Cancer Res. 2007 Sep 15;67(18):8653-61.

22.

Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia.

Sellmann L, Gesk S, Walter C, Ritgen M, Harder L, Martín-Subero JI, Schroers R, Siemer D, Nückel H, Dyer MJ, Dührsen U, Siebert R, Dürig J, Küppers R.

Br J Haematol. 2007 Jul;138(2):217-20.

PMID:
17593029
23.

The GNAS1 T393C polymorphism is associated with disease progression and survival in chronic lymphocytic leukemia.

Frey UH, Nückel H, Sellmann L, Siemer D, Küppers R, Dürig J, Dührsen U, Siffert W.

Clin Cancer Res. 2006 Oct 1;12(19):5686-92.

24.

Association of a novel regulatory polymorphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.

Nückel H, Frey UH, Bau M, Sellmann L, Stanelle J, Dürig J, Jöckel KH, Dührsen U, Siffert W.

Blood. 2007 Jan 1;109(1):290-7. Epub 2006 Sep 7.

25.

Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.

Hüttmann A, Klein-Hitpass L, Thomale J, Deenen R, Carpinteiro A, Nückel H, Ebeling P, Führer A, Edelmann J, Sellmann L, Dührsen U, Dürig J.

Leukemia. 2006 Oct;20(10):1774-82. Epub 2006 Aug 17.

PMID:
16932341
26.

Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.

Nückel H, Hüttmann A, Klein-Hitpass L, Schroers R, Führer A, Sellmann L, Dührsen U, Dürig J.

Leuk Lymphoma. 2006 Jun;47(6):1053-61.

PMID:
16840197
27.

Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival.

Nückel H, Frey UH, Sellmann L, Bau M, Dürig J, Dührsen U, Siffert W.

Leukemia. 2006 Apr;20(4):724. No abstract available.

PMID:
16453002
28.

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

Schroers R, Griesinger F, Trümper L, Haase D, Kulle B, Klein-Hitpass L, Sellmann L, Dührsen U, Dürig J.

Leukemia. 2005 May;19(5):750-8.

PMID:
15759031
29.

[Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].

Jäckel MC, Sellmann L, Youssef S, Dorudian MA, Füzesi L.

HNO. 2001 Mar;49(3):204-11. German.

PMID:
11320623
30.

Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.

Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L.

Laryngoscope. 2000 Aug;110(8):1339-45.

PMID:
10942137

Supplemental Content

Loading ...
Support Center